High incidence of scrapie induced by repeated injections of subinfectious prion doses

Journal of Virology

Volumn 79, Issue 14, 2005, Pages 8904-8908

  Jacquemot, Catherine ^a   Cuche, Céline ^a   Dormont, Dominique ^b   Lazarini, Françoise ^a  

^a INSTITUT PASTEUR   (France)

^b INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN GROWTH HORMONE; PRION PROTEIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN HOMOGENATE; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; DISEASE COURSE; INCIDENCE; INOCULATION; LD 50; MOUSE; NONHUMAN; PRION DISEASE; PRIORITY JOURNAL; SCRAPIE AGENT; SURVIVAL RATE; VIRUS INFECTIVITY; VIRUS STRAIN; VIRUS TRANSMISSION;

ANIMALIA;

EID: 21644458458     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.14.8904-8908.2005     Document Type: Article

References (24)

1. Beringue, V., M. Demoy, C. I. Lasmezas, B. Gouritin, C. Weingarten, J. P. Deslys, J. P. Andreux, P. Couvreur, and D. Dormont. 2000. Role of spleen macrophages in the clearance of scrapie agent early in pathogenesis. J. Pathol. 190:495-502.
2. Boelle, P. Y., J. Y. Cesbron, A. J. Valleron, G. Thomas, and R. Will. 2004. Epidemiological evidence of higher susceptibility to vCJD in the young. BMC Infect. Dis. 4:26.
3. Bolton, D. C., M. P. McKinley, and S. B. Prusiner. 1982. Identification of a protein that purifies with the scrapie prion. Science 218:1309-1311.
4. Brandel, J. P., M. Preece, P. Brown, E. Croes, J. L. Laplanche, Y. Agid, R. Will, and A. Alperovitch. 2003. Distribution of codon 129 genotype in human growth hormone-treated CJD patients in France and the UK. Lancet 362:128-130.
5. Brown, P., M. Preece, J. P. Brandel, T. Sato, L. McShane, I. Zerr, A. Fletcher, R. G. Will, M. Pocchiari, N. R. Cashman, J. H. d'Aignaux, L. Cervenakova, J. Fradkin, L. B. Schonberger, and S. J. Collins. 2000. Iatrogenic Creutzfeldt-Jakob disease at the millennium. Neurology 55:1075-1081.
6. Carp, R. I., and S. M. Callahan. 1982. Effect of mouse peritoneal macrophages on scrapie infectivity during extended in vitro incubation. Intervirology 17:201-207.
7. Coste, J., M. Letrait, J. C. Carel, J. P. Tresca, P. Chatelain, P. Rochiccioli, J. L. Chaussain, and J. C. Job. 1997. Long-term results of growth hormone treatment in France in children of short stature: population, register based study. BMJ 315:708-713.
8. Demaimay, R., K. Adjou, C. Lasmezas, F. Lazarini, K. Cherifi, M. Seman, J. P. Deslys, D. Dormont, P. Castelnau, and J. F. Chermann. 1994. Pharmacological studies of a new derivative of amphotericin B, MS-8209, in mouse and hamster scrapie. J. Gen. Virol. 75:2499-2503.
9. Diringer, H., M. Beekes, and U. Oberdieck. 1994. The nature of the scrapie agent: the virus theory. Ann. N. Y. Acad. Sci. 724:246-258.
10. Diringer, H., J. Roehmel, and M. Beekes. 1998. Effect of repeated oral infection of hamsters with scrapie. J. Gen. Virol. 79:609-612.
11. Gibbs, C. J., Jr., D. M. Asher, P. W. Brown, J. E. Fradkin, and D. C. Gajdusek. 1993. Creutzfeldt-Jakob disease infectivity of growth hormone derived from human pituitary glands. N. Engl. J. Med. 328:358-359.
12. Gravenor, M. B., N. Stallard, R. Curnow, and A. R. McLean. 2003. Repeated challenge with prion disease: the risk of infection and impact on incubation period. Proc. Natl. Acad. Sci. USA 100:10960-10965.
13. Hill, A. F., and J. Collinge. 2003. Subclinical prion infection in humans and animals. Br. Med. Bull. 66:161-170.
14. Kimberlin, R., and C. Walker. 1988. Pathogenesis of experimental scrapie, p. 37-62. In G. B. J. Marsh (ed.), Novel infectious agents and the central nervous system. Ciba Found. Symp. no. 135. John Wiley & Sons, Chichester, United Kingdom.
15. Lasmezas, C. I., J. P. Deslys, R. Demaimay, K. T. Adjou, J. J. Hauw, and D. Dormont. 1996. Strain specific and common pathogenic events in murine models of scrapie and bovine spongiform encephalopathy. J. Gen. Virol. 77:1601-1609.
16. Lazarini, F., F. Boussin, J. P. Deslys, M. Tardy, and D. Dormont. 1994. Astrocyte gene expression in experimental mouse scrapie. J. Comp. Pathol. 111:87-98.
17. Lazarini, F., J. P. Deslys, and D. Dormont. 1992. Variations in prion protein and glial fibrillary acidic protein mRNAs in the brain of scrapie-infected newborn mouse. J. Gen. Virol. 73:1645-1648.
18. + myeloid dendritic cells in vitro. J. Virol. 76:12259-12264.
19. Mills, J. L., L. B. Schonberger, D. K. Wysowski, P. Brown, S. J. Durako, C. Cox, F. Kong, and J. E. Fradkin. 2004. Long-term mortality in the United States cohort of pituitary-derived growth hormone recipients. J. Pediatr. 144:430-436.
20. Mouillet-Richard, S., M. Ermonval, C. Chebassier, J. L. Laplanche, S. Lehmann, J. M. Launay, and O. Kellermann. 2000. Signal transduction through prion protein. Science 289:1925-1928.
21. Swerdlow, A. J., C. D. Biggins, P. Adlard, M. E. Jones, and M. A. Preece. 2003. Creutzfeldt-Jakob disease in United Kingdom patients treated with human pituitary growth hormone. Neurology 61:783-791.
22. Taylor, D. M., I. McConnell, and C. E. Ferguson. 2000. Closely similar values obtained when the ME7 strain of scrapie agent was titrated in parallel by two individuals in separate laboratories using two sublines of C57BL mice. J. Virol. Methods 86:35-40.
23. Thackray, A. M., M. A. Klein, A. Aguzzi, and R. Bujdoso. 2002. Chronic subclinical prion disease induced by low-dose inoculum. J. Virol. 76:2510-2517.
24. Will, R. G. 2003. Acquired prion disease: iatrogenic CJD, variant CJD, kuru. Br. Med. Bull. 66:255-265.